Chemotherapy With Targeted-Immunotherapy for Newly Diagnosed Ph+ ALL
Clinical trial NCT07493161 · RECRUITING
Trial details
- NCT number
- NCT07493161
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-10
- Primary completion
- 2028-03-31
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.